Fasting conditions in clinical oncology trials and drug labelling - Authors' reply

Lancet Oncol. 2017 Sep;18(9):e507. doi: 10.1016/S1470-2045(17)30599-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Drug Labeling*
  • Fasting*
  • Medical Oncology